-
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 23-26 February 2026
27 Feb 2026 14:00 GMT
… Trypanosoma brucei gambiense. This medicine simplifies treatment of first- and second … Pharmaceuticals (iloperidone) received a negative opinion from the CHMP for the treatment … the use of Jorveza (budesonide) for the treatment of eosinophilic oesophagitis, a …
-
Clinical Efficacy of Acupuncture as Adjunctive Therapy for Cough Variant Asthma: Study Protocol for a Pilot Randomized Controlled Trial
25 Feb 2026 09:24 GMT
… trial results will adhere to the Consolidated Standards of Reporting Trials … treatment after study completion.
Basic Treatment and Rescue Medication … receive budesonide-formoterol dry powder inhaler (budesonide … Vries TW. Adverse drug reactions of montelukast …
-
Alopecia Areata – Effects of Treatment with Upadacitinib – Two Case Reports
19 Feb 2026 09:25 GMT
… biopsy decisions, and treatment planning, particularly when … an effective drug for the treatment of several … medical history consists of early-onset asthma treated with budesonide … doctors a potential new way of treatment in cases of AA.
Conclusions
Treatment …
-
Rare Disease Day 2026: Kidney Diseases Enter Optimistic Therapeutic Era
01 Mar 2026 00:20 GMT
… FDA approvals supported by pivotal clinical trial data. In IgAN, budesonide … diagnosis, monitoring, and treatment selection, fostering a … shift toward precision medicine in rare kidney … 7, 2024.
Novartis Pharmaceuticals Corporation. Novartis investigational …
-
<![CDATA[Budesonide–Glycopyrronium–Formoterol Found to Reduce Severe Exacerbations in Uncontrolled Asthma]]>
13 Feb 2026 19:02 GMT
… pooled analysis across both trials evaluated annualized severe exacerbation … were considered treatment related.1
The investigators concluded that budesonide–glycopyrronium– … published in The Lancet Respiratory Medicine. News release. AstraZeneca. February …
-
Positive and clinically meaningful results from the Phase III KALOS and LOGOS trials for BREZTRI in patients with uncontrolled asthma published in The Lancet Respiratory Medicine
13 Feb 2026 18:14 GMT
… #47;LABA) medicines: S ymbicort (budesonide/formoterol … approved for the treatment of chronic obstructive … inhibitors and tricyclic antidepressants, as these may … HEALTH CLINICAL TRIALS RESEARCH SCIENCE PHARMACEUTICAL BIOTECHNOLOGY
SOURCE: AstraZeneca …
-
Positive and clinically meaningful results from the Phase III KALOS and LOGOS trials for Breztri in patients with uncontrolled asthma published in…
13 Feb 2026 10:12 GMT
… trials published in The Lancet Respiratory Medicine showed AstraZeneca’s Breztri Aerosphere (budesonide … combination therapy approved for the treatment of chronic obstructive pulmonary … ,300 randomised patients.
The trial design was optimised to evaluate …
-
Inhalation: A Smart Strategy and Increasing Potential for Drug Delivery
11 Feb 2026 17:18 GMT
… both patients and doctors to know how, … budesonide inhalation may be effective in randomized controlled trials … treatments and patient-centric medicine. The future outlook of inhalation drugs … Pulmonary Delivery of Biological Drugs. Pharmaceutics. 2020;12(11): …
-
14 Medications You Shouldn’t Take With Grapefruit
09 Feb 2026 23:27 GMT
… effectiveness.
1. Certain Statins
Certain statins and grapefruit do … estrogen-containing medications, such as hormonal contraceptive pills or … the body. This includes budesonide, a steroid used in … that breaks down these medications.
High drug levels can lead …
-
<![CDATA[TrumpRx Launches, Offering Cash-Paying Patients Discounted Drugs]]>
07 Feb 2026 02:33 GMT
… White House for pharmaceutical companies to price drugs in the United … for these high-demand medications—especially glucagon-like peptide … Other drugs featured on the website, like albuterol/budesonide ( … Patients deserve to leave the doctor’s office, go to …
About
© 1995-2026